AbbVie announced the initiation of a Phase 3 trial evaluating the safety and efficacy of veliparib in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer.
Six percent of patients with colorectal cancer (CRC) have interval cancers, which develop within six to 60 months of colonoscopy.
The use of neoadjuvant and adjuvant chemotherapy for the treatment of muscle-invasive bladder cancer is associated with a survival benefit in the general population, and may be underutilized.
Higher hospital charge and increased length of stay for patients aged 80 years and older post-resection
High intake of saturated fats is associated with increased risk of certain subtypes of breast cancer.
With the resignation of U.S. Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face.
While millions of Americans still feel hamstrung by medical expenses, a new government report shows that some people are getting relief.
US Health and Human Services Secretary Kathleen Sebelius is stepping down from her position, after overseeing the troubled rollout of the Affordable Care Act.
A small number of doctors received at least $3 million each in Medicare payments in 2012, for a total of nearly $1.5 billion.
Most services included in specialty medical societies' Top 5 lists for the Choosing Wisely campaign are based on evidence demonstrating equivalent but not superior benefit.
Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.
A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.
The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.
ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.
Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.
Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.
The combined treatment was associated with a reduced risk of biochemical and clinical progression compared with radiotherapy alone.
Danish study reveals a 10% prevalence of osteoporosis among men due to start androgen-deprivation therapy.
Only 17% and 20% of patients undergoing radical or partial nephrectomy, respectively, had a renal mass biopsy in advance of surgery.
The nadir should be below 0.01 ng/mL because even levels of 0.01 to 0.2 ng/mL predict an increased risk of adverse outcomes.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|